• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过共结晶和低共熔物形成相结合提高萘普生的溶出度

Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.

作者信息

Kim Hakyeong, Jang Soeun, Kim Il Won

机构信息

Department of Chemical Engineering, Soongsil University, Seoul 06978, Korea.

出版信息

Pharmaceutics. 2021 Apr 25;13(5):618. doi: 10.3390/pharmaceutics13050618.

DOI:10.3390/pharmaceutics13050618
PMID:33923065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8145234/
Abstract

Improving dissolution properties of active pharmaceutical ingredients (APIs) is a critical step in drug development with the increasing occurrence of sparingly soluble APIs. Cocrystal formation is one of the methods to alter the physicochemical properties of APIs, but its dissolution behavior in biorelevant media has been scrutinized only in recent years. We investigated the combined strategy of cocrystallization and eutectic formation in this regard and utilized the cocrystal model system of naproxen and three pyridinecarboxamide isomers. Binary melting diagrams were constructed to discover the eutectic compositions of the three cocrystals with excess amounts of pyridinecarboxamides. The melt-crystallized eutectics and cocrystals were compared in their dissolution behaviors with respect to neat naproxen. The eutectics enhanced the early dissolution rates of the cocrystals in both the absence and presence of biologically relevant bile salt and phospholipid components, whereas the cocrystal dissolution was expedited and delayed, respectively. The combined strategy in the present study will be advantageous in maximizing the utility of the pharmaceutical cocrystals.

摘要

随着难溶性活性药物成分(APIs)的出现日益增多,改善其溶出特性是药物研发中的关键步骤。共结晶形成是改变活性药物成分物理化学性质的方法之一,但近年来其在生物相关介质中的溶解行为才受到审视。在这方面,我们研究了共结晶和低共熔形成的联合策略,并利用了萘普生和三种吡啶甲酰胺异构体的共结晶模型系统。构建二元熔点图以发现三种共晶体与过量吡啶甲酰胺的低共熔组成。将熔融结晶的低共熔物和共晶体与纯萘普生的溶解行为进行了比较。在不存在和存在生物相关胆盐和磷脂成分的情况下,低共熔物均提高了共晶体的早期溶出速率,而共晶体的溶解分别加快和延迟。本研究中的联合策略将有利于最大限度地发挥药物共晶体的效用。

相似文献

1
Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.通过共结晶和低共熔物形成相结合提高萘普生的溶出度
Pharmaceutics. 2021 Apr 25;13(5):618. doi: 10.3390/pharmaceutics13050618.
2
Eutectic Formation of Naproxen with Some Dicarboxylic Acids.萘普生与某些二元羧酸的低共熔物形成
Pharmaceutics. 2021 Dec 4;13(12):2081. doi: 10.3390/pharmaceutics13122081.
3
Binary Mixtures of Some Active Pharmaceutical Ingredients with Fatty Alcohols-The Criteria of Successful Eutectic Formation and Dissolution Improvement.某些活性药物成分与脂肪醇的二元混合物——成功形成低共熔物及改善溶解的标准
Pharmaceutics. 2020 Nov 16;12(11):1098. doi: 10.3390/pharmaceutics12111098.
4
Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.伊曲康唑新型共晶:相图、形成热力学和溶解度的见解。
Int J Pharm. 2021 Apr 15;599:120441. doi: 10.1016/j.ijpharm.2021.120441. Epub 2021 Mar 3.
5
Cocrystallization of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicines.中药活性药物成分的共结晶。
Chem Pharm Bull (Tokyo). 2023;71(5):326-333. doi: 10.1248/cpb.c22-00728.
6
Enhancing Dissolution Rate and Antibacterial Efficiency of Azithromycin through Drug-Drug Cocrystals with Paracetamol.通过与对乙酰氨基酚形成药物-药物共晶体提高阿奇霉素的溶出速率和抗菌效率。
Antibiotics (Basel). 2021 Aug 4;10(8):939. doi: 10.3390/antibiotics10080939.
7
Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering.通过共晶工程改善源自中药的活性药物成分的物理化学和生物药剂学性质。
Pharmaceutics. 2021 Dec 15;13(12):2160. doi: 10.3390/pharmaceutics13122160.
8
Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.通过与烟酰胺共晶化同时改善布洛芬和氟比洛芬的机械性能、溶解性能和吸湿性。
Pharm Res. 2012 Jul;29(7):1854-65. doi: 10.1007/s11095-012-0709-5. Epub 2012 Feb 23.
9
Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.共晶及其在原料药和食品添加剂领域的应用。
Curr Pharm Des. 2018;24(21):2339-2348. doi: 10.2174/1381612824666180522102732.
10
Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.制备难溶性药物的共晶体以提高其在水性介质中的溶出度
Pharmaceutics. 2018 Jul 31;10(3):108. doi: 10.3390/pharmaceutics10030108.

引用本文的文献

1
Application of cosolvency and cocrystallization approach to enhance acyclovir solubility.采用共溶剂法和共结晶法提高阿昔洛韦的溶解度。
BMC Chem. 2025 Jul 30;19(1):226. doi: 10.1186/s13065-025-01591-2.
2
Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model.新型血管紧张素 II 受体脑啡肽酶抑制剂(ARNi)-S086 在葡聚糖硫酸钠(DSS)大鼠模型中的降压作用
Front Cardiovasc Med. 2024 Feb 14;11:1348897. doi: 10.3389/fcvm.2024.1348897. eCollection 2024.
3
Recent Advances on the Biological Study of Pharmaceutical Cocrystals.

本文引用的文献

1
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study.无定形固体分散体以及纳米颗粒对体外溶出和体内测试的贡献:以氯硝柳胺为例的研究
Pharmaceutics. 2021 Jan 14;13(1):97. doi: 10.3390/pharmaceutics13010097.
2
Binary Mixtures of Some Active Pharmaceutical Ingredients with Fatty Alcohols-The Criteria of Successful Eutectic Formation and Dissolution Improvement.某些活性药物成分与脂肪醇的二元混合物——成功形成低共熔物及改善溶解的标准
Pharmaceutics. 2020 Nov 16;12(11):1098. doi: 10.3390/pharmaceutics12111098.
3
The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
药物共晶的生物学研究进展。
AAPS PharmSciTech. 2022 Nov 17;23(8):303. doi: 10.1208/s12249-022-02451-1.
4
Two Novel Co-Crystals of Naproxen: Comparison of Stability, Solubility and Intermolecular Interaction.萘普生的两种新型共晶体:稳定性、溶解度和分子间相互作用的比较
Pharmaceuticals (Basel). 2022 Jun 29;15(7):807. doi: 10.3390/ph15070807.
5
Eutectic Formation of Naproxen with Some Dicarboxylic Acids.萘普生与某些二元羧酸的低共熔物形成
Pharmaceutics. 2021 Dec 4;13(12):2081. doi: 10.3390/pharmaceutics13122081.
pH值和剂量/溶解度比在共晶溶解、药物过饱和及沉淀方面的作用。
Eur J Pharm Sci. 2020 Sep 1;152:105422. doi: 10.1016/j.ejps.2020.105422. Epub 2020 Jun 10.
4
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems.成功地口服递送给水难溶性药物既依赖于药物的腔内行为,也依赖于合适的先进药物传递系统。
Eur J Pharm Sci. 2019 Sep 1;137:104967. doi: 10.1016/j.ejps.2019.104967. Epub 2019 Jun 25.
5
Simultaneously Improving Mechanical, Formulation, and In Vivo Performance of Naproxen by Co-Crystallization.通过共结晶同时改善萘普生的机械性能、制剂性能和体内性能。
AAPS PharmSciTech. 2018 Oct;19(7):3249-3257. doi: 10.1208/s12249-018-1152-7. Epub 2018 Sep 7.
6
Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update.无定形固体分散体和纳米晶体技术在难溶性药物传递中的应用-更新。
Int J Pharm. 2018 Jan 15;535(1-2):379-392. doi: 10.1016/j.ijpharm.2017.10.051. Epub 2017 Nov 8.
7
Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal Fluid.不同模拟肠液版本中存在的增溶纳米聚集体的特征。
J Phys Chem B. 2017 Dec 7;121(48):10869-10881. doi: 10.1021/acs.jpcb.7b08622. Epub 2017 Nov 21.
8
Levetiracetam+nonsteroidal anti-inflammatory drug binary systems: A contribution to the development of new solid dosage forms.左乙拉西坦与非甾体抗炎药二元体系:对新固体制剂开发的贡献。
Int J Pharm. 2017 Nov 25;533(1):1-13. doi: 10.1016/j.ijpharm.2017.09.012. Epub 2017 Sep 8.
9
Characterization of co-existing colloidal structures in fasted state simulated fluids FaSSIF: A comparative study using AF4/MALLS, DLS and DOSY.禁食状态模拟流体FaSSIF中共存胶体结构的表征:使用AF4/MALLS、DLS和DOSY的比较研究
J Pharm Biomed Anal. 2017 Oct 25;145:531-536. doi: 10.1016/j.jpba.2017.07.014. Epub 2017 Jul 18.
10
Enhancement of dissolution rate through eutectic mixture and solid solution of posaconazole and benznidazole.通过泊沙康唑和苄硝唑的共晶混合物及固溶体提高溶解速率。
Int J Pharm. 2017 Jun 15;525(1):32-42. doi: 10.1016/j.ijpharm.2017.04.021. Epub 2017 Apr 12.